medigraphic.com
Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán

2005, Number 1

<< Back Next >>

Rev Biomed 2005; 16 (1)

Infection and disease by Toxoplasma gondii in humans and animals during 23 years of observation in Ciego de Ávila province, Cuba.

Suárez-Hernández M, González-Fernández A, Gardón-Quirola BY, Martínez-Sánchez R

Language: Spanish
References: 42
Page: 21-27
PDF size: 44.94 Kb.


ABSTRACT

The aim of the present investigation is to evaluate the studies carried out on Toxoplasma in animals and humans hereby determining the prevalence of antibodies and morbidity in both groups. This study has a descriptive design and was carried out between 1980 and 2002. The techniques used on animals and humans for epidemiological studies were intradermoreaction (toxoplasmine), complement fixation reaction and inmunoflourescence.
The highest seropositivity in animals was detected using the inmunoflourescent technique.
No differences were detected among the poblation groups studied nor between normal and retarded children. The prevalence was greater among rural children.
There is no information on neither animal or human morbidity, that even though there has been a lack of diagnostic means, there is a preliminary evaluation of the afectations on public health.
Complement fixation reaction and inmunoflourescence were used to detect cases among humans. The majority of patients had the following motives for study: adenopathologies, febrile syndrome and ophthalmpathologies.
Cases of toxoplasmosis in HIV/AIDS patients were reported for the first time during the period 1998-2002.


REFERENCES

  1. 1.- Mombro M. Congenital toxoplasmosis 10 years follows Eur J Pediatr 1995; 154: 635-9.

  3. 2.- Mittal V, Bhatia R, Schgal S. Prevalence of Toxoplasma antibodies among woman with BOH and general population in Delhi. J Communic Dis 1990; 22: 223-6.

  5. 3.- Thiermann E, Atlas A, Loren M. Apreciaciones sobre el riesgo relativo de la transmisión sanguínea. Parasitología al día 1988; 12 (2): 81-83.

  7. 4.- Chiari H, Pereira D. Toxoplasmosis humana adquirida a través de ingestión de leche de cabra. Mem Inst Oswaldo Cruz 1984; 79: 337-40.

  9. 5.- Almeida M, Magalhaes C, Ferreira L, Moraes P, Pezati N, Neres R. Isolamento de Toxoplasma gondii de carnes y derivados provenientes de región endémica de Toxoplasmosis ocular. Arch Bras Oftalmol 1990; 53:60-6.

  10. 6.- Dubey JP, Thulliez P, Powell EC. Toxoplasma gondii in lowa Sows comparision of antibody titers to isolation of Toxoplasma gondii by bioassaayss in mice and cats. J Parasitol 1995; 81: 48-53.

  12. 7.- Aguilar F. Parasitología medica, 2da edición. Ciudad de Guatemala: Editorial Delgado; 1991. p. 281-91.

  14. 8.- Zemburowa K, Roczniark M, Sokolowska B. The comparision of serological test used in diagnosing active toxoplasmosis. Wiad Parazitol. 1990; 36:121-7.

  16. 9.- Suárez M. Presentación de los dos primeros casos de toxoplasmosis congénita en la provincia Ciego de Ávila, Cuba. Rev Esp Pediatr 1998; 54: 271-4.

  18. 10.- Suárez M. Toxoplasmosis en la provincia de Ciego de Ávila, Cuba. Rev Epidem Antioquia 1998; 23: 67-74.

  20. 11.- Morillo N, Bonjante G. Primer hallazgo de Toxoplasma gondii en un bovino del estado de Yaracuy, Venezuela. Kasmera 1994; 22: 71-8.

  22. 12.- Rivera F, Calderón E, Olivera J, Conde J, Echamiz G. Comparación de tres pruebas serológicas para el diagnostico de la toxoplasmosis. Infectología 1988; 8: 127-30.

  24. 13.- Skinner L J, Timperley AC, Wightman D, Chatterton JM, Ho Yen Do. Simultaneous diagnosis of toxoplasmosis in goats and goatower is family. Scand J Infect Dis 1990; 22: 359-61.

  26. 14.- Dubey J P. Duration of Inmunity to shedding of Toxoplasma gondii oocysts by cat, J Parasitol 1995; 81: 410-5.

  28. 15.- Centre for ocupational health and safety. Toxoplasmosis: A summary of ocupational health concern. Edited by Canadian Centre for occupational health and safety. Hamilton; 1989. p. 1-3.

  30. 16.- Martínez R, Machin R, Fachado A, Pividal J, Cruz R, Suárez M. Algunos resultados sobre una encuesta de Toxoplasma. Investigación clínica 1991; 32: 13-26.

  32. 17.- Lappalalnen M. Cost- benefit analysis of screening for toxoplasmosis during pregnancy. Scand J infects Dis 1995; 27: 265-72.

  34. 18.- Mole J R, Suárez D, Alonso F, Piquera N. Lo que hacemos para prevenir la toxoplasmosis congénita en Manzanillo. Rev Cub Med Gen Integr 1992; 8: 330-2.

  36. 19.- Villalonga J F, Antonide Jogma P S, García C. Estudio de pacientes pediátricos con toxoplasmosis. Ciencias Médicas. San Miguel de Tucuman 1986; 1: 37-47.

  38. 20.- Mombro M. Congenital toxoplasmosis 10 years follow Eur J Pediatr 1995; 154: 635-9.

  40. 21.- Naloska T, Cariatfu T. Toxoplasmosis is caused of sensoneural. Mem Inst Oswaldo Cruz 1994; 89: 485-90.

  42. 22.- Russo M, Galanti B. Prevention of congenital toxoplasmosis. Clínica Terapéutica Roma 1990; 134: 383-92.




2020     |     www.medigraphic.com